The essentials
dsm-firmenich AG is a Swiss-Dutch fragrance, flavor, nutrition, and health ingredients group, formed by the merger of Royal DSM (Netherlands) and Firmenich (Switzerland) which became effective on 8 May 2023. The combined entity is registered in Kaiseraugst (Switzerland), keeps the Firmenich Perfumery and Beauty division headquartered in Geneva (Switzerland), and is dual-listed on Euronext Amsterdam and SIX Swiss Exchange under ticker DSFIR (dsm-firmenich corporate communications and investor relations, accessed 2026-05-29).
The group employs approximately 30,000 people across about 60 countries. Reported sales in fiscal year 2024 were roughly EUR 12.8 billion (about 14 billion USD), with the Perfumery and Beauty business representing one of the largest contributions to the group's fragrance-related revenue. The wider portfolio spans flavor and beverage solutions, animal nutrition, health and bioscience, and food and beverage ingredients (dsm-firmenich Annual Report 2024, accessed 2026-05-29).
Before the merger, Firmenich operated for 128 years as a privately held fragrance and flavor company, the largest of its kind outside of public markets. It was founded in 1895 in Geneva by Philippe Chuit and Martin Naef and stayed under family stewardship until its combination with DSM. The transaction added publicly traded scrutiny to a culture that had been able to invest in long-cycle R&D without quarterly earnings pressure (Perfumer & Flavorist industry reporting, accessed 2026-05-29).
The 2023 merger and corporate structure
The merger was announced on 31 May 2022 and structured as a share-for-share combination. It became legally effective on 8 May 2023, with the listed entity adopting the lowercase name dsm-firmenich AG and a new Kaiseraugst registered seat. Firmenich shareholders, primarily the Firmenich family, received roughly one-third of the combined group; DSM shareholders held the remainder. The strategic rationale combined fragrance and flavor expertise (Firmenich) with biotechnology, fermentation, and nutrition science (DSM).
The combined organization is structured around four business units: Perfumery and Beauty, Taste and Beyond, Health Nutrition and Care, and Animal Nutrition and Health. Perfumery and Beauty consolidates the historical Firmenich fragrance business and continues to be led from Geneva (dsm-firmenich corporate communications, accessed 2026-05-29).
Firmenich heritage and Geneva laboratories
Firmenich was founded in 1895 in Geneva as Chuit, Naef & Cie by chemist Philippe Chuit and businessman Martin Naef. The company became Firmenich after Charles Firmenich joined his father-in-law's enterprise. Its Meyrin and La Plaine production sites near Geneva became the operational heart of the company throughout the 20th century. Firmenich pioneered organic chemistry applied to perfumery, notably collaborating with Nobel laureate Leopold Ruzicka on the molecular structure of natural musks.
The Firmenich Perfumery School, integrated into dsm-firmenich's training structure since the merger, trained successive generations of in-house perfumers. The Geneva laboratories remain the operational center of Perfumery and Beauty within the combined group (Perfumer & Flavorist historical profile, accessed 2026-05-29).
DSM heritage and biotechnology assets
DSM, originally Dutch State Mines, was founded in 1902 in Heerlen (Netherlands) as a coal-mining concern and transformed during the 20th century into a chemicals and life sciences company. By the early 2020s, DSM had divested its commodity chemicals businesses and focused on nutrition, health, and biosciences. Its fermentation capabilities, biotechnology platforms, and ingredients portfolio brought to the merger expertise that complemented Firmenich's synthetic-chemistry and composition heritage.
Within the combined group, the DSM legacy supports biotechnology-derived fragrance ingredients, fermentation-based vitamin and lipid platforms, and a strong position in animal nutrition. The convergence of biotech-sourced molecules with traditional perfumery is a stated strategic priority (dsm-firmenich corporate communications, accessed 2026-05-29).
Captive molecules: Galaxolide, Norlimbanol, Ambrox
Galaxolide is a synthetic polycyclic musk first commercialized by IFF in 1965, but widely produced and used by Firmenich for decades within fabric care, personal care, and fine fragrance. It provides a soft, clean, diffusive musk note. Concentration limits set by IFRA Standards address aquatic environmental persistence concerns. Norlimbanol is a Firmenich captive with a dry, woody character used as a modifier in sandalwood and vetiver compositions. Ambrox, an ambroxide variant, anchors many modern ambery and skin-effect drydowns.
Firmenich's captive portfolio also includes a range of macrocyclic musks, oudh and woody molecules, and biotech-derived alternatives. The captive library is a core competitive asset because it gives in-house perfumers olfactive effects that competitors cannot reproduce until patents expire (Perfumer & Flavorist ingredient reviews, accessed 2026-05-29).
In-house perfumers and niche credits
Dominique Ropion is the most cited Firmenich perfumer in niche perfumery. He composed Carnal Flower (Editions de Parfums Frédéric Malle, 2005) and Portrait of a Lady (Editions de Parfums Frédéric Malle, 2010), along with multiple Frédéric Malle and Louis Vuitton credits. Alberto Morillas, also at Firmenich, signed CK One (Calvin Klein, 1994) and the Mugler Cologne range. Nathalie Lorson contributed compositions for Maison Francis Kurkdjian and several Hermès fragrances.
Other Firmenich-affiliated perfumers active in niche include Honorine Blanc, Harry Frémont, and Jacques Cavallier-Belletrud (since 2012 in-house perfumer at Louis Vuitton, who began his career at Firmenich). The diversity of niche credits reflects Firmenich's long-standing relationships with houses such as Frédéric Malle, Maison Francis Kurkdjian, and the LVMH fragrance portfolio (Fragrantica perfumer profiles, accessed 2026-05-29).
Strategy and position versus Givaudan
Within the Big Four fragrance and flavor suppliers, dsm-firmenich is generally placed second by composition revenue, behind Givaudan and ahead of IFF and Symrise. The two leaders compete directly for briefs from major niche houses, including Frédéric Malle, Maison Francis Kurkdjian, and several Le Labo and By Kilian projects. House decisions on which supplier to engage typically reflect perfumer preferences, captive molecule access, and existing brief relationships.
Post-merger, dsm-firmenich has communicated a strategy combining synthetic chemistry, biotechnology, and digital tools for formula creation. The group continues to invest in sustainable sourcing for natural ingredients, captive molecule renewal, and fermentation-based alternatives to scarce or regulated raw materials (dsm-firmenich Annual Report 2024 and strategic communications, accessed 2026-05-29).
Sources
- dsm-firmenich AG, Annual Report 2024 and investor relations communications. Accessed 2026-05-29.
- dsm-firmenich AG, corporate communications on the May 2023 merger between DSM and Firmenich. Accessed 2026-05-29.
- Perfumer & Flavorist, historical profile of Firmenich and ingredient reviews on Galaxolide, Norlimbanol, and Ambrox. Accessed 2026-05-29.
- Fragrantica, perfumer profile database, entries on Dominique Ropion, Alberto Morillas, and Nathalie Lorson. Accessed 2026-05-29.